NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-114-2018-0-JP-02 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS JP DIV 2025-142520 Pending
NIAID E-032-2019-0-US-02 Nanoparticle-Based Influenza Virus Vaccines and Uses Thereof US CON 19/312,888 Pending
NIAID E-143-2025-0-US-02 COMPOSITIONS FOR OVERCOMING TETRACYCLINE ANTIBIOTIC RESISTANCE AND
METHODS OF USE THEREOF 		US ORD 19/313,798 Pending
NIEHS E-022-2023-0-EP-01 MUTANT ARA H 2 AND ARA H 6 PROTEINS AND USES THEREOF EP National Stage 24716910.5 Pending
NINDS E-070-2024-0-ZA-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS ZA National Stage 2025/07163 Pending
NINDS E-070-2024-0-RU-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS RU National Stage 2025123430 Pending
NCI E-167-2017-0-AU-01 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY AU DIV 2025223746 Pending
NHLBI E-202-2024-1-PC-01 Development of SMYD3 PROTACs PCT PCT PCT/US2025/043429 Pending
NINDS E-070-2024-0-EP-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS EP National Stage 24710931.7 Pending
NIEHS E-022-2023-0-US-02 MUTANT ARA H 2 AND ARA H 6 PROTEINS AND USES THEREOF US National Stage 19/159,114 Pending
NCI E-017-2017-0-AU-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES AU DIV 2025220853 Pending
NINDS E-070-2024-0-DZ-01 Methods of Diagnosing and Treating Multiple Sclerosis DZ National Stage 2055-12-25 Pending
NCATS E-112-2023-0-KR-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF KR National Stage 10-2025-7027957 Pending
NCATS E-112-2023-0-EP-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF EP National Stage 24751027.4 Pending
NIDCD E-220-2024-0-PC-01 USING ARTIFICIAL INTELLIGENCE ALGORITHMS FOR DATA MODELING OF FUNCTIONAL HUMAN BRAIN ACTIVITY VIA FUNCTIONAL MAGNETIC RESONANCE IMAGING PCT PCT COMB PCT/US2025/042553 Expired
CC E-140-2023-0-US-02 IMPROVEMENT OF VIRAL VECTOR MEDIATED GENE THERAPY TRANSDUCTION AND SAFETY OR PROMOTING VIRAL CLEARANCE AND/OR INHIBITING VIRAL INFECTIVITY BY TARGETING CLASS B SCAVENGER RECEPTORS US ORD 19/303,076 Pending
NCI E-094-2018-0-US-02 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF US DIV 19/302,338 Pending
NCATS E-112-2023-0-IN-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IN National Stage 202517078291 Pending
NCI E-234-2023-0-PC-01 ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY PCT PCT PCT/US2025/042148 Pending
NEI E-203-2023-0-EP-01 APPARATUS AND METHOD FOR EXTRACELLULAR IMPEDANCE SPECTROSCOPY OF EPITHELIA EP National Stage 24705896.9 Pending
NEI E-203-2023-0-GB-01 APPARATUS AND METHOD FOR EXTRACELLULAR IMPEDANCE SPECTROSCOPY OF EPITHELIA GB National Stage 2513195.4 Pending
NEI E-005-2023-0-EP-01 SYSTEMS AND METHODS FOR DEEP LEARNING TO DETECT RETINAL VASCULITIS ON COLOR FUNDUS PHOTOGRAPHS OF PATIENTS WITH UVEITIS EP National Stage 24710954.9 Pending
NIAID E-086-2020-0-VN-01 AN IMMUNOGEN, A PROTEIN NANOPARTICLE COMPRISING THE IMMUNOGEN, A VIRUS-LIKE PARTICLE COMPRISING THE IMMUNOGEN AND AN IMMUNOGENIC COMPOSITION COMPRISING THE IMMUNOGEN VN DIV 1-2025-05755 Pending
NINDS E-195-2023-1-PC-01 SHORT HAIRPIN RNA-MEDIATED INHIBITION OF HERV-K EXPRESSION AND USES THEREOF PCT PCT PCT/US2025/041065 Pending
NIAID E-191-2018-0-AU-01 Improved Methods Of Manufacturing Peptide-Based Vaccines AU DIV 2025213648 Pending
NINDS E-070-2024-0-SA-01 Methods of Diagnosing and Treating Multiple Sclerosis SA National Stage 1120255643 Pending
NIBIB E-040-2023-1-EP-01 INTUBATION SYSTEM AND CHAMBER TANK EP National Stage 24706269.8 Abandoned
NLM E-107-2010-2-US-46 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 19/289,498 Pending
NIAID E-211-2024-0-PC-01 SARS-CoV-2 VACCINE PCT PCT PCT/US2025/040365 Pending
NCI E-214-2024-0-PC-01 CHIMERIC ANTIGEN RECEPTORS TARGETING THE GAMMA DELTA T CELL RECEPTOR PCT PCT PCT/US2025/040252 Pending
NEI E-005-2023-0-US-02 SYSTEMS AND METHODS FOR DEEP LEARNING TO DETECT RETINAL VASCULITIS ON COLOR FUNDUS PHOTOGRAPHS OF PATIENTS WITH UVEITIS US National Stage 19/153,124 Pending
NINDS E-061-2023-0-US-02 SYSTEMS AND METHODS FOR PATTERNED MULTI-SLICE EXCITATION IN MAGNETIC RESONANCE IMAGING US National Stage 19/153,204 Pending
NCATS E-112-2023-0-US-02 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 19/152,632 Pending
NCATS E-112-2023-0-BR-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF BR National Stage BR112025016055-9 Pending
NCATS E-112-2023-0-AU-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF AU National Stage 2024215598 Pending
NCATS E-112-2023-0-CA-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CA National Stage 3281710 Pending
NCATS E-112-2023-0-JP-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2025-544712 Pending
NIAID E-200-2024-0-PC-01 WEST NILE VIRUS NEUTRALIZING MONOCLONAL ANTIBODIES PCT PCT PCT/US2025/039922 Pending
NINDS E-070-2024-0-US-02 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID US CON 19/285,681 Pending
NINDS E-070-2024-0-CN-01 Methods of Diagnosing and Treating Multiple Sclerosis CN National Stage 202480009996.4 Pending
NCATS E-112-2023-0-MX-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF MX National Stage MX/a/2025/008887 Pending
NINDS E-070-2024-0-BR-01 Methods of Diagnosing and Treating Multiple Sclerosis BR National Stage BR112025015889-9 Pending
NCI E-199-2022-0-EP-01 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY EP National Stage 24709907.0 Pending
NINDS E-070-2024-0-MX-01 Methods of Diagnosing and Treating Multiple Sclerosis MX National Stage MX/a/2025/008840 Pending
NIDDK E-032-2023-0-EP-01 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION EP National Stage 23853653.6 Pending
NIAID E-131-2015-2-EP-11 NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE EP DIV 25192258.9 Pending
NCI E-265-2015-0-KR-01 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS KR DIV 10-2025-7025325 Pending
NINDS E-070-2024-0-JP-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID JP National Stage 2025-543818 Pending
NINDS E-070-2024-0-IL-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID IL National Stage 322398 Pending
NCI E-199-2022-0-US-02 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY US National Stage 19/151,190 Pending